These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34668889)

  • 61. Stem cell transplantation into the fetal recipient: challenges and prospects.
    Bui TH; Jones DR
    Curr Opin Obstet Gynecol; 1998 Apr; 10(2):105-8. PubMed ID: 9551304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In utero hematopoietic stem-cell transplantation--a match for mom.
    Parolini O
    N Engl J Med; 2011 Mar; 364(12):1174-5. PubMed ID: 21428775
    [No Abstract]   [Full Text] [Related]  

  • 63. Reappraisal of in utero stem cell transplantation based on long-term results.
    Touraine JL; Raudrant D; Golfier F; Rebaud A; Sembeil R; Roncarolo MG; Bacchetta R; D'Oiron R; Lambert T; Gebuhrer L
    Fetal Diagn Ther; 2004; 19(4):305-12. PubMed ID: 15192288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transplantation of hematopoietic stem cells in utero.
    Zanjani ED; Almeida-Porada G; Ascensao JL; MacKintosh FR; Flake AW
    Stem Cells; 1997; 15 Suppl 1():79-92; discussion 93. PubMed ID: 9368328
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In utero transplantation of haemopoietic stem cells.
    Flake AW
    Best Pract Res Clin Haematol; 2001 Dec; 14(4):671-83. PubMed ID: 11924915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The biology and ethics of banking fetal liver hematopoietic stem cells for in utero transplantation.
    Mychaliska GB; Muench MO; Rice HE; Leavitt AD; Cruz J; Harrison MR
    J Pediatr Surg; 1998 Feb; 33(2):394-9. PubMed ID: 9498425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prenatal Allogeneic Tolerance in Mice Remains Stable Despite Potent Viral Immune Activation.
    Strong BS; Ryken KO; Lee AE; Turner LE; Wadhwani RK; Newkold TJ; Alhajjat AM; Heusel JW; Shaaban AF
    J Immunol; 2015 Oct; 195(8):4001-9. PubMed ID: 26363051
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In utero transplantation of stem cells in humans: technical aspects and clinical experience during pregnancy.
    Raudrant D; Touraine JL; Rebaud A
    Bone Marrow Transplant; 1992; 9 Suppl 1():98-100. PubMed ID: 1354533
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preclinical Canine Model of Graft-versus-Host Disease after In Utero Hematopoietic Cell Transplantation.
    Vrecenak JD; Pearson EG; Todorow CA; Li H; Johnson MP; Flake AW
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1795-1801. PubMed ID: 29802901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In-utero stem cell transplantation: clinical use and therapeutic potential.
    De Santis M; De Luca C; Mappa I; Cesari E; Quattrocchi T; Spagnuolo T; Visconti D; Noia G; Caruso A
    Minerva Ginecol; 2011 Aug; 63(4):387-98. PubMed ID: 21747347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stem cell therapy in utero.
    Pschera H
    J Perinat Med; 2000; 28(5):346-54. PubMed ID: 11125924
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cellular therapy.
    Flake AW; Zanjani ED
    Obstet Gynecol Clin North Am; 1997 Mar; 24(1):159-77. PubMed ID: 9086524
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fetal Surgical conditions and the unraveling of maternal-fetal tolerance.
    MacKenzie TC
    J Pediatr Surg; 2016 Feb; 51(2):197-9. PubMed ID: 26653947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
    Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
    Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.
    Ureña-Bailén G; Block M; Grandi T; Aivazidou F; Quednau J; Krenz D; Daniel-Moreno A; Lamsfus-Calle A; Epting T; Handgretinger R; Wild S; Mezger M
    CRISPR J; 2023 Feb; 6(1):5-16. PubMed ID: 36662546
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The hopes and fears of in utero gene therapy for genetic disease--a review.
    Coutelle C; Themis M; Waddington S; Gregory L; Nivsarkar M; Buckley S; Cook T; Rodeck C; Peebles D; David A
    Placenta; 2003 Oct; 24 Suppl B():S114-21. PubMed ID: 14559040
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transplacental Gene Delivery (TPGD) as a Noninvasive Tool for Fetal Gene Manipulation in Mice.
    Nakamura S; Watanabe S; Ando N; Ishihara M; Sato M
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775372
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34
    Cromer MK; Vaidyanathan S; Ryan DE; Curry B; Lucas AB; Camarena J; Kaushik M; Hay SR; Martin RM; Steinfeld I; Bak RO; Dever DP; Hendel A; Bruhn L; Porteus MH
    Mol Ther; 2018 Oct; 26(10):2431-2442. PubMed ID: 30005866
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
    Dudek AM; Porteus MH
    Front Immunol; 2021; 12():660302. PubMed ID: 34122418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.